论文部分内容阅读
目的:通过对1527例住院患者免疫增强药的使用调查和分析,探讨本院临床免疫增强药的使用情况,为其合理使用提供依据。方法:利用药房软件系统综合分析我院2009年3～4月1527例住院患者免疫增强药的使用情况。结果:结核病研究所5个科室住院患者免疫增强药使用率为90.25%,其他29个临床科室使用率为21.23%;单一、二联、三联、四联及以上使用率分别为85.94%,37.35%,6.63%及1.21%。用药频度列前6位的药品是草分枝杆菌F.U.36注射液、注射用胸腺肽、薄芝糖肽注射液、注射用胸腺五肽(上海华源)、重组人白细胞介素-2(Ala)注射液、乌本美司胶囊;药物利用指数大于1的药品有7种,占免疫增强药调查品种的21.21%。结论:我院免疫增强药的使用基本合理,但也存在不合理用药情况。
Objective: To investigate and analyze the use of immunostimulants in 1527 inpatients to explore the use of clinical immunostimulants in our hospital, and to provide basis for their rational use. Methods: The use of pharmacy software system in our hospital from March 2009 to April 1527 cases of hospitalized patients with immune-enhancing drug use. Results: The utilization rate of immunostimulants was 90.25% and the other 29 clinical departments were 21.23%. The single, double, triple, quadruple and above rates were 85.94% and 37.35% respectively, , 6.63% and 1.21% respectively. Drug frequency of the top 6 drugs are Mycobacterium phlei FU36 injection, injection of thymosin, thin glycopeptide injection, injection of thymopentin (Shanghai Huayuan), recombinant human interleukin -2 (Ala ) Injection, Wubenmeisi capsule. There were 7 kinds of drugs whose drug utilization index was greater than 1, accounting for 21.21% of the investigated products of the immune enhancing drug. Conclusion: The use of immunostimulants in our hospital is basically reasonable, but there are also unreasonable drug use cases.